Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocate Alisha Bridges, Grace Wright, MD, PhD, president of the Association of Women in Rheumatology in New York City, and Naureen Kabani, MD, a rheumatologist with SUNY Downstate in Brooklyn, New York, discuss how this new program will help close gaps and improve access to care for people of color with psoriatic disease.